Hand Held Class Iv Laser Therapy

Acute and Chronic Pain

Arthritis

Back Pain

Bursitis

Carpal Tunnel

Fibromyalgia

Ligament Sprains

Muscle Strain

Soft Tissue Injuries

Tendonitis

Tennis Elbow

Peripheral Neuropathy

1.Combine 904nm 808nm 650nm into one unit

2.Wavelength can be selected.

3.Humanized design and easy to operated

4. The frequency can be selected.

5.No Side Effects , no trauma

6.The treatment efficiency rate over 90%

7.Highly Effective for Patient (more than 90% efficacy)

8.Superior Alternative to: Analgesics, NSAID’s, Other Medications, Other Modalities

9.Can Reduce the Need for Surgery

1.Objectives: While low-level laser therapy (LLLT) is not typically included in major knee osteoarthritis (KOA) treatment guidelines, this study aimed to assess whether a dose-response relationship exists for LLLT in the treatment of KOA.

2.Design: Systematic review and meta-analysis.

3.Data Sources: Eligible studies were sourced from PubMed, Embase, the Cumulative Index to Nursing and Allied Health Literature, Physiotherapy Evidence Database, and the Cochrane Central Register of Controlled Trials, as of February 18, 2019. Additional sources included reference lists, books, citations, and expert recommendations.

4.Eligibility Criteria for Study Selection: Only randomized placebo-controlled trials involving participants diagnosed with KOA based on the American College of Rheumatology and/or Kellgren/Lawrence criteria were included. These studies had to apply LLLT to the participants’ knees, with no restrictions based on language.

5.Data Extraction and Synthesis: Data from the included trials were synthesized using random effects meta-analysis and were further subdivided by dose according to the treatment guidelines from the World Association for Laser Therapy. The risk of bias in each trial was assessed using Cochrane’s risk-of-bias tool.

6.Results: A total of 22 trials (n=1063) were analyzed. The risk of bias was deemed insignificant. Overall, LLLT significantly reduced pain compared to placebo, both at the end of the therapy (14.23 mm reduction on the Visual Analogue Scale (VAS), 95% CI 7.31 to 21.14) and at follow-up visits 1-12 weeks post-treatment (15.92 mm reduction on VAS, 95% CI 6.47 to 25.37). Subgroup analysis indicated that pain reduction was more significant with the recommended LLLT doses, both at the end of therapy (18.71 mm reduction, 95% CI 9.42 to 27.99) and during follow-up (23.23 mm reduction on VAS, 95% CI 10.60 to 35.86). The peak reduction in pain occurred during follow-ups 2-4 weeks after treatment (31.87 mm reduction, 95% CI 18.18 to 45.56). In addition, LLLT was also shown to significantly reduce disability. No adverse events were reported.

7.Conclusion: LLLT effectively reduces pain and disability in patients with KOA when applied at doses of 4-8 J with a 785-860 nm wavelength, or 1-3 J with a 904 nm wavelength per treatment spot.

Hot Tags: hand held class iv laser therapy, China hand held class iv laser therapy manufacturers, suppliers, factory, iv laser therapy, class 4 laser therapy, level 4 laser therapy, class iv laser treatment, class iv laser therapy, class 4 medical laser